Vivoryon Therapeutics NV
AEX:VVY

Watchlist Manager
Vivoryon Therapeutics NV Logo
Vivoryon Therapeutics NV
AEX:VVY
Watchlist
Price: 1.56 EUR -1.89% Market Closed
Market Cap: 46.2m EUR

Vivoryon Therapeutics NV
Investor Relations

The company is headquartered in Halle, Sachsen-Anhalt and currently employs 16 full-time employees. The company went IPO on 2014-10-27.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Dec 4, 2025
Q3 2025 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls

Management

Mr. Frank T. Weber M.D.
Chairman of the Management Board, CEO, Chief Medical Officer & Executive Director
No Bio Available
Ms. Anne Doering C.F.A.
CSO & Investor Relations Officer, CFO, Member of the Management Board and Executive Director
No Bio Available
Dr. Michael Schaeffer Ph.D.
Chief Business Officer, Member of the Management Board & Executive Director
No Bio Available
Dr. Manuela Bader
Director of Investor Relations & Communications
No Bio Available
Dr. Konrad Glund
Co-Founder & Advisor
No Bio Available
Dr. Hendrik Liebers
Advisor
No Bio Available

Contacts

Address
SACHSEN-ANHALT
HALLE
Weinbergweg 22
Contacts
+493455559900.0
www.vivoryon.com